AbbVie
ABBV
#27
Rank
โ‚ฌ328.44 B
Marketcap
185,69ย โ‚ฌ
Share price
1.78%
Change (1 day)
-2.39%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : โ‚ฌ119.53 Billion

According to AbbVie's latest financial reports the company's total liabilities are โ‚ฌ119.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ116.78 B-7.79%
2024-12-31โ‚ฌ126.65 B12.63%
2023-12-31โ‚ฌ112.45 B-0.73%
2022-12-31โ‚ฌ113.28 B-2.13%
2021-12-31โ‚ฌ115.75 B3.57%
2020-12-31โ‚ฌ111.76 B28.69%
2019-12-31โ‚ฌ86.84 B46.54%
2018-12-31โ‚ฌ59.26 B8.25%
2017-12-31โ‚ฌ54.74 B-6.31%
2016-12-31โ‚ฌ58.43 B30.11%
2015-12-31โ‚ฌ44.91 B111.94%
2014-12-31โ‚ฌ21.18 B18.45%
2013-12-31โ‚ฌ17.88 B0.08%
2012-12-31โ‚ฌ17.87 B205.89%
2011-12-31โ‚ฌ5.84 B43.1%
2010-12-31โ‚ฌ4.08 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚ฌ105.76 B-11.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ74.88 B-37.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ71.38 B-40.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ9.74 B-91.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ31.71 B-73.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ62.32 B-47.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ56.94 B-52.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ52.99 B-55.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ1.20 B-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA